These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16187778)

  • 1. Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.
    Evins AE; Deckersbach T; Cather C; Freudenreich O; Culhane MA; Henderson DC; Green MF; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychiatry; 2005 Sep; 66(9):1184-90. PubMed ID: 16187778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
    Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
    J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation.
    Tønnesen P; Tonstad S; Hjalmarson A; Lebargy F; Van Spiegel PI; Hider A; Sweet R; Townsend J
    J Intern Med; 2003 Aug; 254(2):184-92. PubMed ID: 12859700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
    George TP; Vessicchio JC; Termine A; Bregartner TA; Feingold A; Rounsaville BJ; Kosten TR
    Biol Psychiatry; 2002 Jul; 52(1):53-61. PubMed ID: 12079730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia.
    Moss TG; Sacco KA; Allen TM; Weinberger AH; Vessicchio JC; George TP
    Drug Alcohol Depend; 2009 Sep; 104(1-2):94-9. PubMed ID: 19447570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of bupropion on nicotine craving and withdrawal.
    Shiffman S; Johnston JA; Khayrallah M; Elash CA; Gwaltney CJ; Paty JA; Gnys M; Evoniuk G; DeVeaugh-Geiss J
    Psychopharmacology (Berl); 2000 Jan; 148(1):33-40. PubMed ID: 10663415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
    Evins AE; Mays VK; Rigotti NA; Tisdale T; Cather C; Goff DC
    Nicotine Tob Res; 2001 Nov; 3(4):397-403. PubMed ID: 11694208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-year follow-up of a smoking cessation trial in patients with schizophrenia: increased rates of smoking cessation and reduction.
    Evins AE; Cather C; Rigotti NA; Freudenreich O; Henderson DC; Olm-Shipman CM; Goff DC
    J Clin Psychiatry; 2004 Mar; 65(3):307-11; quiz 452-3. PubMed ID: 15096068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bupropion on cognitive performance during initial tobacco abstinence.
    Perkins KA; Karelitz JL; Jao NC; Gur RC; Lerman C
    Drug Alcohol Depend; 2013 Nov; 133(1):283-6. PubMed ID: 23726977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia.
    George TP; Vessicchio JC; Sacco KA; Weinberger AH; Dudas MM; Allen TM; Creeden CL; Potenza MN; Feingold A; Jatlow PI
    Biol Psychiatry; 2008 Jun; 63(11):1092-6. PubMed ID: 18096137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia.
    Evins AE; Cather C; Deckersbach T; Freudenreich O; Culhane MA; Olm-Shipman CM; Henderson DC; Schoenfeld DA; Goff DC; Rigotti NA
    J Clin Psychopharmacol; 2005 Jun; 25(3):218-25. PubMed ID: 15876899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
    Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
    J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial.
    Ahluwalia JS; Harris KJ; Catley D; Okuyemi KS; Mayo MS
    JAMA; 2002 Jul 24-31; 288(4):468-74. PubMed ID: 12132977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial.
    Nanovskaya TN; Oncken C; Fokina VM; Feinn RS; Clark SM; West H; Jain SK; Ahmed MS; Hankins GDV
    Am J Obstet Gynecol; 2017 Apr; 216(4):420.e1-420.e9. PubMed ID: 27890648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
    Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
    JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the "self-medication" hypothesis in schizophrenia.
    Boggs DL; Surti TS; Esterlis I; Pittman B; Cosgrove K; Sewell RA; Ranganathan M; D'Souza DC
    Schizophr Res; 2018 Apr; 194():62-69. PubMed ID: 28392208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for smoking cessation and reduction in individuals with schizophrenia.
    Tsoi DT; Porwal M; Webster AC
    Cochrane Database Syst Rev; 2010 Jun; (6):CD007253. PubMed ID: 20556777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.
    Hays JT; Hurt RD; Decker PA; Croghan IT; Offord KP; Patten CA
    Nicotine Tob Res; 2009 Jul; 11(7):859-67. PubMed ID: 19483180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.